๐ Weekly Report August 02, 2026 (PDF) โ Download
๐ Podcast August 02, 2026 (MP3) โ Play & Download
iPS Cells & Regenerative Medicine Weekly Report August 2, 2026
Author of this article
้ข้ฃ่จไบ
-
iPS Cells & Regenerative Medicine Weekly Report October 11, 2026 -
Daraxonrasib: First RAS inhibitor FDA approval specs for 2026
-
3D Bioprinting: Multi-layered tumor organoid specs for 2026
-
Aglatimagene: Candel Therapeutics NSCLC Phase 2a 2026 roadmap
-
3D Bioprinting: Tsinghua University vascular organoid specs
-
FAYUVI: Ultragenyx AAV9 gene therapy FDA approval and specs
-
Lonvo-z: Intellia Therapeutics’ FDA approval for CRISPR therapy
-
Sartorius Eveo: Cell therapy costs cut 90% to under $40,000
